nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—TNFSF11—periodontitis	0.754	0.911	CbGaD
Lenalidomide—PTGS2—periodontitis	0.0732	0.0885	CbGaD
Lenalidomide—TNFSF11—jaw skeleton—periodontitis	0.0285	0.291	CbGeAlD
Lenalidomide—TNFSF11—periosteum—periodontitis	0.0215	0.219	CbGeAlD
Lenalidomide—TNFSF11—Osteoclast Signaling—ACP5—periodontitis	0.0121	0.173	CbGpPWpGaD
Lenalidomide—TNFSF11—Osteoblast Signaling—TNFRSF11B—periodontitis	0.0112	0.159	CbGpPWpGaD
Lenalidomide—TNFSF11—Osteoclast Signaling—TNFRSF11B—periodontitis	0.0101	0.143	CbGpPWpGaD
Lenalidomide—TNFSF11—tongue—periodontitis	0.0091	0.0928	CbGeAlD
Lenalidomide—TNFSF11—mouth—periodontitis	0.00612	0.0624	CbGeAlD
Lenalidomide—CDH5—endothelium—periodontitis	0.00597	0.0608	CbGeAlD
Lenalidomide—TNFSF11—IL6-mediated signaling events—LBP—periodontitis	0.0056	0.0799	CbGpPWpGaD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—ACP5—periodontitis	0.00452	0.0644	CbGpPWpGaD
Lenalidomide—TNFSF11—connective tissue—periodontitis	0.00375	0.0382	CbGeAlD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—TNFRSF11B—periodontitis	0.00375	0.0534	CbGpPWpGaD
Lenalidomide—CDH5—trigeminal ganglion—periodontitis	0.0034	0.0346	CbGeAlD
Lenalidomide—TNFSF11—IL6-mediated signaling events—TIMP1—periodontitis	0.00322	0.0459	CbGpPWpGaD
Lenalidomide—CDH5—parotid gland—periodontitis	0.00321	0.0327	CbGeAlD
Lenalidomide—CDH5—connective tissue—periodontitis	0.00282	0.0288	CbGeAlD
Lenalidomide—PTGS2—periosteum—periodontitis	0.0028	0.0285	CbGeAlD
Lenalidomide—CDH5—epithelium—periodontitis	0.00268	0.0273	CbGeAlD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—VCAM1—periodontitis	0.00236	0.0336	CbGpPWpGaD
Lenalidomide—CRBN—trigeminal ganglion—periodontitis	0.00216	0.022	CbGeAlD
Lenalidomide—CRBN—parotid gland—periodontitis	0.00204	0.0208	CbGeAlD
Lenalidomide—TNFSF11—IL6-mediated signaling events—CRP—periodontitis	0.00198	0.0282	CbGpPWpGaD
Lenalidomide—Pomalidomide—TNF—periodontitis	0.00195	0.412	CrCbGaD
Lenalidomide—TNFSF11—Differentiation Pathway—FGF2—periodontitis	0.00145	0.0206	CbGpPWpGaD
Lenalidomide—Thalidomide—TNF—periodontitis	0.00126	0.266	CrCbGaD
Lenalidomide—PTGS2—endothelium—periodontitis	0.00103	0.0105	CbGeAlD
Lenalidomide—TNFSF11—Differentiation Pathway—TGFB1—periodontitis	0.000943	0.0134	CbGpPWpGaD
Lenalidomide—Pomalidomide—PTGS2—periodontitis	0.000926	0.196	CrCbGaD
Lenalidomide—PTGS2—mouth—periodontitis	0.000796	0.00812	CbGeAlD
Lenalidomide—TNFSF11—IL6-mediated signaling events—IL6—periodontitis	0.000723	0.0103	CbGpPWpGaD
Lenalidomide—TNFSF11—Differentiation Pathway—IL6—periodontitis	0.000711	0.0101	CbGpPWpGaD
Lenalidomide—Thalidomide—PTGS2—periodontitis	0.000597	0.126	CrCbGaD
Lenalidomide—PTGS2—trigeminal ganglion—periodontitis	0.000588	0.00599	CbGeAlD
Lenalidomide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—periodontitis	0.000543	0.00774	CbGpPWpGaD
Lenalidomide—PTGS2—Eicosanoid Synthesis—GGT1—periodontitis	0.000499	0.00711	CbGpPWpGaD
Lenalidomide—PTGS2—connective tissue—periodontitis	0.000488	0.00497	CbGeAlD
Lenalidomide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—periodontitis	0.000485	0.0069	CbGpPWpGaD
Lenalidomide—PTGS2—epithelium—periodontitis	0.000463	0.00472	CbGeAlD
Lenalidomide—PTGS2—Overview of nanoparticle effects—CRP—periodontitis	0.000418	0.00595	CbGpPWpGaD
Lenalidomide—ABCB1—Drug Induction of Bile Acid Pathway—VDR—periodontitis	0.000396	0.00564	CbGpPWpGaD
Lenalidomide—ABCB1—trigeminal ganglion—periodontitis	0.000364	0.00371	CbGeAlD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—periodontitis	0.000344	0.00491	CbGpPWpGaD
Lenalidomide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—periodontitis	0.00032	0.00456	CbGpPWpGaD
Lenalidomide—ABCB1—epithelium—periodontitis	0.000286	0.00292	CbGeAlD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—IL6—periodontitis	0.000284	0.00404	CbGpPWpGaD
Lenalidomide—PTGS2—Arachidonic acid metabolism—GGT1—periodontitis	0.000277	0.00395	CbGpPWpGaD
Lenalidomide—PTGS2—Overview of nanoparticle effects—CXCL8—periodontitis	0.000272	0.00387	CbGpPWpGaD
Lenalidomide—CDH5—Signaling by VEGF—IL6—periodontitis	0.000268	0.00382	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCL3—periodontitis	0.000253	0.00361	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—MPO—periodontitis	0.000242	0.00344	CbGpPWpGaD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—periodontitis	0.000234	0.00333	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—MPO—periodontitis	0.000233	0.00332	CbGpPWpGaD
Lenalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.000227	0.00324	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—periodontitis	0.000223	0.00317	CbGpPWpGaD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—periodontitis	0.000208	0.00297	CbGpPWpGaD
Lenalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.000192	0.00273	CbGpPWpGaD
Lenalidomide—PTGS2—Overview of nanoparticle effects—TNF—periodontitis	0.000189	0.00269	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—FCGR2A—periodontitis	0.000187	0.00266	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—VIP—periodontitis	0.000183	0.00261	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL13—periodontitis	0.00018	0.00256	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—GGT1—periodontitis	0.000177	0.00251	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL17A—periodontitis	0.000166	0.00236	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCR2—periodontitis	0.000163	0.00232	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CCR2—periodontitis	0.000162	0.0023	CbGpPWpGaD
Lenalidomide—PTGS2—Overview of nanoparticle effects—IL6—periodontitis	0.000153	0.00217	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—periodontitis	0.000135	0.00192	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCR2—periodontitis	0.000127	0.00181	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ADRB1—periodontitis	0.000126	0.0018	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—periodontitis	0.000125	0.00178	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—CRP—periodontitis	0.000122	0.00175	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL1A—periodontitis	0.000116	0.00165	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL1A—periodontitis	0.000113	0.00161	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL10—periodontitis	0.000113	0.0016	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL4—periodontitis	0.000112	0.0016	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL4—periodontitis	0.00011	0.00156	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NTRK1—periodontitis	0.000103	0.00147	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—CCL2—periodontitis	0.000101	0.00144	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—NOS2—periodontitis	9.97e-05	0.00142	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MMP3—periodontitis	9.61e-05	0.00137	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—periodontitis	9.32e-05	0.00133	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TLR4—periodontitis	9.29e-05	0.00132	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	8.97e-05	0.00128	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—NOS2—periodontitis	8.83e-05	0.00126	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—periodontitis	8.72e-05	0.00124	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IFNG—periodontitis	8.57e-05	0.00122	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CCL2—periodontitis	7.97e-05	0.00114	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL1B—periodontitis	7.64e-05	0.00109	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IFNG—periodontitis	6.78e-05	0.000965	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IFNG—periodontitis	6.62e-05	0.000943	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SLC52A3—periodontitis	6.43e-05	0.000916	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	6.36e-05	0.000906	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CXCL8—periodontitis	6.3e-05	0.000898	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCL2—periodontitis	6.25e-05	0.00089	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CXCL8—periodontitis	6.16e-05	0.000877	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL1B—periodontitis	6.04e-05	0.000861	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL1B—periodontitis	5.91e-05	0.000841	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—MMP9—periodontitis	5.7e-05	0.000812	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—FGF2—periodontitis	5.65e-05	0.000805	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—TNF—periodontitis	5.55e-05	0.00079	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC52A3—periodontitis	5.39e-05	0.000767	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCL8—periodontitis	4.94e-05	0.000704	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	4.9e-05	0.000698	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TGFB1—periodontitis	4.7e-05	0.000669	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—TGFB1—periodontitis	4.59e-05	0.000654	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL6—periodontitis	4.47e-05	0.000638	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MMP9—periodontitis	4.47e-05	0.000637	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TNF—periodontitis	4.39e-05	0.000625	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—LTF—periodontitis	4.37e-05	0.000623	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—TNF—periodontitis	4.29e-05	0.000611	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	3.97e-05	0.000565	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC52A3—periodontitis	3.82e-05	0.000544	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ACP5—periodontitis	3.79e-05	0.00054	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TGFB1—periodontitis	3.68e-05	0.000525	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL6—periodontitis	3.54e-05	0.000504	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	3.47e-05	0.000495	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	3.19e-05	0.000455	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ACP5—periodontitis	3.17e-05	0.000452	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	3.13e-05	0.000446	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	2.98e-05	0.000425	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	2.84e-05	0.000404	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL6—periodontitis	2.77e-05	0.000395	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	2.26e-05	0.000323	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ACP5—periodontitis	2.25e-05	0.000321	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	2.11e-05	0.000301	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	1.91e-05	0.000273	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GGT1—periodontitis	1.77e-05	0.000252	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS2—periodontitis	1.33e-05	0.00019	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARA—periodontitis	1.26e-05	0.00018	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GGT1—periodontitis	1.25e-05	0.000178	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FGF2—periodontitis	1.09e-05	0.000155	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARA—periodontitis	8.96e-06	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TGFB1—periodontitis	7.09e-06	0.000101	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGS2—periodontitis	5.83e-06	8.3e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6—periodontitis	5.35e-06	7.62e-05	CbGpPWpGaD
